24 Nov 2015
Enquiry // Levosimendan API or key intermediates required by leading Indian generic company [EN00178]
A leading Indian generic company is looking for Levosimendan (brand name: Simdax) or its key intermediates. The product’s innovator Orion obtained approval to market the drug in Sweden in 2000 and since then 60 countries worldwide have approved the drug. It remains non licensed in the US and is used in the management of acutely decompensated congestive heart failure.
refarmed@refarmed.ch
Dear Sirs,
In case your query is still valid, please contact us in the mail address enclosed as we could be interested in offering Levosimendan.
Thanks, best regards
Giancarlo Porta
04:24, 09 Feb 2016